Skip to main content

A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin’s lymphoma patient

Virologica Sinica volume 28, pages 49–52 (2013)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  • Alexopoulou A, Dourakis S P, Pandelidaki H, Archimandritis A J and Karayiannis P. 2006. Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine. J Med Virol, 78: 1043–1046.

    Article  PubMed  CAS  Google Scholar 

  • Awerkiew S, Daumer M, Reiser M, Wend U C, Pfister H, Kaiser R, Willems W R and Gerlich W H. 2007. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol, 38: 83–86.

    Article  PubMed  Google Scholar 

  • Carman W F, Korula J, Wallace L, MacPhee R, Mimms L and Decker R. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet, 345: 1406–1407.

    Article  PubMed  CAS  Google Scholar 

  • Dahlen D D, Broudy V C and Drachman J G. 2003. Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood, 102: 102–108.

    Article  PubMed  CAS  Google Scholar 

  • Ferreira R, Carvalheiro J, Torres J, Fernandes A, Giestas S, Mendes S, Agostinho C and Campos M J. 2012. Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: A case report and literature review. Saudi J Gastroenterol, 18: 277–281.

    Article  PubMed  Google Scholar 

  • Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N and Sueoka E. 2009. Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier. Ann Oncol, 20: 2013–2017.

    Article  PubMed  CAS  Google Scholar 

  • Iannitto E, Minardi V, Calvaruso G, Mule A, Ammatuna E, Di Trapani R, Ferraro D, Abbadessa V, Craxi A and Di Stefano R. 2005. Hepatitis B virus reactivation and alemtuzumab therapy. Eur J Haematol, 74: 254–258.

    Article  PubMed  Google Scholar 

  • Lee I C, Huang Y H, Chu C J, Lee P C, Lin H C and Lee S D. 2010. Hepatitis B virus reactivation after 23 months of rituximab-based chemotherapy in an HBsAg-negative, anti-HBs-positive patient with follicular lymphoma. J Chin Med Assoc, 73: 156–160.

    Article  PubMed  Google Scholar 

  • Matsue K, Kimura S, Takanashi Y, Iwama K, Fujiwara H, Yamakura M and Takeuchi M. 2010. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Cancer, 116: 4769–4776.

    Article  PubMed  Google Scholar 

  • Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti M E, Taliani G and Zanetti A R. 2001. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis, 184: 905–908.

    Article  PubMed  CAS  Google Scholar 

  • Moerman B, Moons V, Sommer H, Schmitt Y and Stetter M. 2004. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab, 50: 159–162.

    PubMed  CAS  Google Scholar 

  • Nainan O V, Khristova M L, Byun K, Xia G, Taylor P E, Stevens C E and Margolis H S. 2002. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol, 68: 319–327.

    Article  PubMed  CAS  Google Scholar 

  • Onozawa M, Hashino S, Izumiyama K, Kahata K, Chuma M, Mori A, Kondo T, Toyoshima N, Ota S, Kobayashi S, Hige S, Toubai T, Tanaka J, Imamura M and Asaka M. 2005. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation, 79: 616–619.

    Article  PubMed  Google Scholar 

  • Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde K H, Neuhaus P and Gerken G. 1998. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology, 27: 254–263.

    Article  PubMed  CAS  Google Scholar 

  • Sarrecchia C, Cappelli A and Aiello P. 2005. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother, 11: 189–191.

    Article  PubMed  Google Scholar 

  • Sera T, Hiasa Y, Michitaka K, Konishi I, Matsuura K, Tokumoto Y, Matsuura B, Kajiwara T, Masumoto T, Horiike N and Onji M. 2006. Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med, 45: 721–724.

    Article  PubMed  Google Scholar 

  • Tsutsumi Y, Kawamura T, Saitoh S, Yamada M, Obara S, Miura T, Kanamori H, Tanaka J, Asaka M, Imamura M and Masauzi N. 2004. Hepatitis B virus reactivation in a case of non-Hodgkin’s lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leuk Lymphoma, 45: 627–629.

    Article  PubMed  Google Scholar 

  • Westhoff T H, Jochimsen F, Schmittel A, Stoffler-Meilicke M, Schafer J H, Zidek W, Gerlich W H and Thiel E. 2003. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood, 102: 1930.

    Article  PubMed  CAS  Google Scholar 

  • Wu C, Shi H, Wang Y, Lu M, Xu Y and Chen X. 2012. A case of hepatitis B reactivation due to the hepatitis B virus escape mutant in a patient undergoing chemotherapy. Virol Sin, 27: 368–371.

    Article  PubMed  Google Scholar 

  • Yamagata M, Murohisa T, Tsuchida K, Okamoto Y, Tsunoda S, Nakamura M, Kusano K, Majima Y, Kuniyoshi T, Iijima M, Sugaya H and Hiraishi H. 2007. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab. Leuk Lymphoma, 48: 431–433.

    Article  PubMed  CAS  Google Scholar 

  • Yeo W, Chan T C, Leung N W, Lam W Y, Mo F K, Chu M T, Chan H L, Hui E P, Lei K I, Mok T S and Chan P K. 2009. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol, 27: 605–611.

    Article  PubMed  CAS  Google Scholar 

  • Zhang J M, Xu Y, Wang X Y, Yin Y K, Wu X H, Weng X H and Lu M. 2007. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis, 44: 1161–1169.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. State Key Lab of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China

    Chunchen Wu, Hui Shi, Mengji Lu & Xinwen Chen

  2. Department of Microbiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Mengji Lu & Yang Xu

  3. Institute of Virology, University Hospital of Essen, Essen, D45122, Germany

    Mengji Lu

Authors
  1. Chunchen Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mengji Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xinwen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Chunchen Wu or Yang Xu.

Additional information

Foundation items: This work was supported by the National Basic Research Priorities Program of China (2011CB 106303), National Natural Science Foundation of China (31200699) and the Fundamental Research Funds for the Central Universities (HUST: 2012QN140).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wu, C., Shi, H., Lu, M. et al. A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin’s lymphoma patient. Virol. Sin. 28, 49–52 (2013). https://doi.org/10.1007/s12250-013-3285-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-013-3285-x

Keywords

  • Lymphoma Patient
  • Virus Reactivation
  • Escape Mutant
  • Virus Escape Mutant